- Home
- PETZ vs ADVB Comparison
PETZ vs ADVB Comparison
Compare PETZ & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- ADVB
- Stock Information
- Founded
- PETZ 2002
- ADVB 2014
- Country
- PETZ China
- ADVB United States
- Employees
- PETZ N/A
- ADVB N/A
- Industry
- PETZ Steel/Iron Ore
- ADVB Medical Specialities
- Sector
- PETZ Industrials
- ADVB Health Care
- Exchange
- PETZ Nasdaq
- ADVB Nasdaq
- Market Cap
- PETZ 9.3M
- ADVB 9.1M
- IPO Year
- PETZ 2017
- ADVB 2025
- Fundamental
- Price
- PETZ $1.03
- ADVB $0.43
- Analyst Decision
- PETZ
- ADVB
- Analyst Count
- PETZ 0
- ADVB 0
- Target Price
- PETZ N/A
- ADVB N/A
- AVG Volume (30 Days)
- PETZ 5.3K
- ADVB 964.6K
- Earning Date
- PETZ 04-28-2025
- ADVB 11-03-2025
- Dividend Yield
- PETZ N/A
- ADVB N/A
- EPS Growth
- PETZ N/A
- ADVB N/A
- EPS
- PETZ 0.26
- ADVB N/A
- Revenue
- PETZ $563,726.00
- ADVB N/A
- Revenue This Year
- PETZ N/A
- ADVB N/A
- Revenue Next Year
- PETZ N/A
- ADVB N/A
- P/E Ratio
- PETZ $5.08
- ADVB N/A
- Revenue Growth
- PETZ 74664.72
- ADVB N/A
- 52 Week Low
- PETZ $0.65
- ADVB $0.34
- 52 Week High
- PETZ $1.74
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- PETZ 52.58
- ADVB N/A
- Support Level
- PETZ $1.02
- ADVB N/A
- Resistance Level
- PETZ $1.10
- ADVB N/A
- Average True Range (ATR)
- PETZ 0.04
- ADVB 0.00
- MACD
- PETZ 0.00
- ADVB 0.00
- Stochastic Oscillator
- PETZ 39.83
- ADVB 0.00
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.